DIETARY SUPPLEMENTS

Subscribe to DIETARY SUPPLEMENTS

FDA Issues Warning Letters to 7 Dietary Supplement Companies for Drug Claims

Posted on November 21, 2022

On November 17, 2022, FDA posted warning letters to 7 companies for selling different dietary supplements with claims that caused the products to be “drugs” in violation of the Federal

…
Continue Reading FDA Issues Warning Letters to 7 Dietary Supplement Companies for Drug Claims

FDA Finalizes NAC Enforcement Discretion Guidance

Posted on August 2, 2022

FDA issued final guidance regarding its decision to exercise enforcement discretion with respect to the sale and distribution of dietary supplements containing N-acetyl-L-cysteine (NAC). The final guidance is substantively identical

…
Continue Reading FDA Finalizes NAC Enforcement Discretion Guidance

Georgia Court Finds Dietary Supplement Labeling Claim within FDA’s Jurisdiction

Posted on June 29, 2022

On June 24, the Court of Appeals of Georgia held that Plaintiff Shawn Smith’s deceptive product labeling case raised questions best left to the FDA.
By way of background, in

…
Continue Reading Georgia Court Finds Dietary Supplement Labeling Claim within FDA’s Jurisdiction

Senate Committee Passes the FDA Safety and Landmark Advancements Act

Posted on June 28, 2022

On June 14, 2022, the Senate Health, Education, Labor, and Pensions (HELP) Committee passed the FDA Safety and Landmark Advancements (FDASLA) Act (S. 4348) which proposes various changes

…
Continue Reading Senate Committee Passes the FDA Safety and Landmark Advancements Act

FDA Releases Draft Guidance on NAC Enforcement

Posted on April 22, 2022

On April 21, 2022 FDA announced the issuance of draft guidance on FDA’s policy regarding dietary supplements containing N-acetyl cysteine (NAC). The guidance details the agency’s intent to exercise enforcement

…
Continue Reading FDA Releases Draft Guidance on NAC Enforcement

Challenge to Dietary Supplement Structure/Function Claims Preempted

Posted on April 5, 2022

On March 31, 2022, the U.S. District Court for the District of Massachusetts held that Plaintiffs’ claims— which alleged that the labels on three of Vitamin Shoppe, Inc.’s dietary supplements

…
Continue Reading Challenge to Dietary Supplement Structure/Function Claims Preempted

Permanent Injunction against Supplement Co.

Posted on March 10, 2022

On March 3, 2022, the United States Government, on behalf of FDA, filed a complaint against Salud Natural Entrepreneur, Inc. (“Salud”), as well as its owner, production manager, and quality

…
Continue Reading Permanent Injunction against Supplement Co.

FDA & FTC Issue Warning Letters to 10 Companies

Posted on September 14, 2021

On September 9, 2021, the Food and Drug Administration (FDA) and Federal Trade Commission (FTC) jointly issued warning letters to 10 companies for illegally selling dietary supplements claiming to treat

…
Continue Reading FDA & FTC Issue Warning Letters to 10 Companies

Senators Unveil Draft Bill with Pathway for CBD

Posted on July 16, 2021

Senators Chuck Schumer (D-NY), Cory Booker (D-NJ), and Ron Wyden (D-OR) unveiled a lengthy discussion draft titled the Cannabis Administration and Opportunity Act on July 14. The draft language is

…
Continue Reading Senators Unveil Draft Bill with Pathway for CBD

New Bipartisan Senate Bill Seeks Movement on CBD

Posted on May 21, 2021

U.S. Senators Ron Wyden (D-OR), Rand Paul (R-KY) and Jeff Merkley (D-OR) introduced S. 1698 on May 19, a bill to allow the use of cannabidiol (CBD) and other hemp

…
Continue Reading New Bipartisan Senate Bill Seeks Movement on CBD